Review





Similar Products

93
Addgene inc qhsaced0044677 recombinant dna pcdna dest47 hddr1 johannessen
Qhsaced0044677 Recombinant Dna Pcdna Dest47 Hddr1 Johannessen, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pDONR223-DDR1+(Plasmid+%2323910)/pm40975064-292-185-193
Average 93 stars, based on 1 article reviews
qhsaced0044677 recombinant dna pcdna dest47 hddr1 johannessen - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc mark cookson
Mark Cookson, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pm40883511-247-51-53
Average 93 stars, based on 1 article reviews
mark cookson - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc pcdna dest47 pink1 c gfp
( A ) Western blot showing <t>Pink1</t> levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .
Pcdna Dest47 Pink1 C Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pmc12550048-12-0-7
Average 93 stars, based on 1 article reviews
pcdna dest47 pink1 c gfp - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc addgene 13316
( A ) Western blot showing <t>Pink1</t> levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .
Addgene 13316, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pmc12550048-12-7-7
Average 93 stars, based on 1 article reviews
addgene 13316 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc cfp pink1
( A ) Western blot showing <t>Pink1</t> levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .
Cfp Pink1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pm40451779-176-12-14
Average 93 stars, based on 1 article reviews
cfp pink1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc pink1gfp plasmid
( A ) Western blot showing <t>Pink1</t> levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .
Pink1gfp Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pm40105243-51-8-14
Average 93 stars, based on 1 article reviews
pink1gfp plasmid - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc gfp pink1 fl
( A ) Western blot showing <t>Pink1</t> levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .
Gfp Pink1 Fl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna+dest47/pcDNA-DEST47+PINK1+C-GFP+(Plasmid+%2313316)/pm40105243-52-0-119
Average 93 stars, based on 1 article reviews
gfp pink1 fl - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


( A ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .

Journal: EMBO Reports

Article Title: Peri-mitochondrial actin filaments inhibit Parkin assembly by disrupting ER-mitochondria contacts

doi: 10.1038/s44319-025-00561-y

Figure Lengend Snippet: ( A ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with 20 µM CCCP for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( B ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of CCCP treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0145 (CCCP 20 Vs CK666 + CCCP 20) (*), P = 0.3731 (CCCP 40 vs CK666 + CCCP 40) (ns), one-way ANOVA used. ( C ) Western blot showing Pink1 levels in HeLa cells overexpressing GFP-Pink1 treated with a combination of 15 µM Oligomycin A and 25 µM Antimycin A for 20 and 40 min in the presence or absence of 100 µM CK666. Actin used as loading control. Molecular weight in kDa. ( D ) Quantification showing relative Pink1 levels in HeLa cells overexpressing GFP-Pink1 following 20 and 40 min of Oligomycin A + Antimycin A treatment in the presence or absence of CK666 (100 µM). N = 3 independent experiments; Error: Mean ±s.d.; P = 0.0017 (A/O 20 Vs CK666 + A/O 20) (**), P = 0.0291 (A/O 40 vs CK666 + A/O 40) (*), one-way ANOVA used. ( E ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with 20 µM CCCP in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. ( F ) Western blot of HeLa cells overexpressing Parkin GFP showing Parkin, phospho-Parkin (S65) and phospho-ubiquitin (S65) upon treatment with a combination of 15 µM Oligomycin A and 25 µM Antimycin A in the presence or absence of CK666 (100 µM) for various time points as shown. Molecular weight in kDa. .

Article Snippet: pcDNA-DEST47 PINK1 C-GFP , Mark Cookson , Addgene: #13316.

Techniques: Western Blot, Control, Molecular Weight, Ubiquitin Proteomics